MediCare Remedies Private limited is one of the fastest growing privately held pharmaceutical companies in India, headquartered at Airoli Navi Mumbai, in the State of Maharashtra with latest in pharmaceutical technology with our R&D experience into one capsule that cure. For us the final result of success is simple: To Provide Quality services with smile. We are committed to the health of the Poor
and needy people. We know that the cost of therapy to them of Oncology drugs. In our endeavor to help the society by allocating some share of the profits to these people we provide them support with formulation drugs through the able hands of the Doctors. As an integrated healthcare solutions provider, we cater to over all Chemotherapy drugs. With presence in over entire states of India & Nepal, we focus on providing high quality, affordable treatment & reduce the toxicity of oncology drugs, dosage overload, improve half life and achieve better site targeting; this is accompanied by the incorporation of new technologies to reduce the risk at advanced stages of R&D
The MediCare product portfolio includes prescription medicines of all latest oncology drugs. MediCare is aligning itself with in areas such as clinical trials, clinical data management, sourcing raw material and support for business processes including analytics. MediCare is best-in-class field force, backed by a nation-wide network of stockiest, ensures that the Company's products are readily available across the nation. Being a social brings responsibility towards the communities in which we operate. MediCare have a Corporate Social Responsibility program that works towards fulfilling basic healthcare, education and other developmental needs of the underserved population. With this dedication and commitment, we believe that the world will be better, healthier and happier by providing the quality drugs with smile. MediCare is committed to developing new and effective healthcare solutions. The values on which the group was founded have always inspired growth and will continue to do so in times to come.
